ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01701583
Recruitment Status : Completed
First Posted : October 5, 2012
Last Update Posted : March 7, 2018
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2016
  Actual Study Completion Date : October 2017